Tumour necrosis factor to treat chronic hepatitis B virus infection
- 4 August 1990
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 336 (8710) , 321-322
- https://doi.org/10.1016/0140-6736(90)91866-9
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.The Journal of Immunology, 1989
- Production of TNF α and IL-1β in association with clearance of hepatitis B virus in interferon treated carriersJournal of Hepatology, 1989
- Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitroBiochemical and Biophysical Research Communications, 1989
- Antiviral Activity of Tumour Necrosis Factor. Synergism with Interferons and Induction of Oligo-2',5'-adenylate SynthetaseJournal of General Virology, 1988
- Interleukin-1 Can Inhibit Interferon-β Synthesis and Its Antiviral Action: Comparison with Tumor Necrosis FactorJournal of Interferon Research, 1988
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Antiviral effects of recombinant tumour necrosis factor in vitroNature, 1986